Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - A substudy to the MERIT-HF trial

European Journal of Heart Failure

Volumn 3, Issue 4, 2001, Pages 463-468

  Lars, Gullestad ^a   Cord, Manhenke ^b   Torbjørn, Aarsland ^b   Rita, Skårdal ^a   Hans, Fagertun ^c   John, Wikstrand ^d   John, Kjekshus ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Hjertelaget Research Foundation   (Norway)

^c Scandinavian Statistical Services   (Norway)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Exercise; Oxygen uptake; Blockade

Indexed keywords

METOPROLOL; PLACEBO;

ADULT; AGED; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EXERCISE TOLERANCE; FEMALE; FOLLOW UP; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGED; CHRONIC DISEASE; CONFIDENCE INTERVALS; DELAYED-ACTION PREPARATIONS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EXERCISE TOLERANCE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; HUMANS; LONG-TERM CARE; MALE; METOPROLOL; MIDDLE AGED; OXYGEN CONSUMPTION; PROBABILITY; REFERENCE VALUES; TREATMENT OUTCOME;

EID: 0034883448     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-9842(01)00146-5     Document Type: Article

References (34)

1. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure
2. The cardiac insufficiency bisoprolol study (CIBIS II): A randomized trial
3. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL randomised intervention trial in congestive heart failure
4. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure. The metoprolol CR/XL randomized intervention trial in congestive heart failure
5. Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man
6. Effect of betaadrenoceptor blockade on exercise performance and metabolism
7. Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: A double-blind, randomized, placebo-controlled trial
8. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy
9. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure
10. Beneficial effects of metoprolol in heart failure associated with coronary artery disease: A randomized trial
11. A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy
12. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy
13. Long-term b-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placebo
14. Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy
15. Effects of shortand long-term of carveldilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy
16. Effects of carvedilol, a vasodilator-β-blocker, in patients with congestive heart failure due to ischemic heart disease
17. Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized study
18. Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy
19. Dose-response of chronic b-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy
20. The effects of ace inhibitors on exercise capacity in the treatment of congestive heart failure
21. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
22. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction
23. Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration Cooperative study
24. Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure. Results from V-HeFT I and V-HeFT II
25. Perceived exertion as an indicator of somatic stress
26. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart
27. Doubleblind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE trial
28. Improved exercise hemodynamic status in dilated cardiomyopathy after betaadrenergic blockade treatment
29. Effects of neurohumoral antagonism on symptoms and quality-of-life in heart failure
30. Effects of selective beta-2-adrenoceptor blockade on serum potassium and exercise performance in normal men
31. Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol, and acebutolol
32. Serial exercise testing and prognosis in selected patients considered for cardiac transplantation
33. Consensus recommendations for the management of chronic heart failure
34. Medical therapy can improve the biological properties of chronically failing heart